Appointment is a First for a Top 10 Biopharmaceutical Company Paris, France, 1-4-2014 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) today announced the appointment of Anne C. Beal, M.D., MPH, to the newly created position of Chief Patient Officer. « … Read the full press release
Posted in Business, France, Management, Pharma & Biotech, Science
Tagged Chief Patient Officer at Sanofi, Dr. Anne C. Beal, Laurence Bollack, Pascale Witz, Sanofi, Sébastien Martel
Companies To Host Investor Conference Call on Alirocumab on March 31 at 9 a.m. EDT Paris, France and Tarrytown, NY, 28-3-2014 — /EuropaWire/ — Sanofi (EURONEXT : SAN and NYSE : SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that data … Read the full press release
Paris, France, 31-1-2014 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that it filed a patent infringement suit against Eli Lilly and Company ( “Lilly”) on January 30, 2014 in the United States District Court for the District of Delaware. In … Read the full press release
Posted in France, Healthcare, Law, Pharma & Biotech
Tagged Eli Lilly, Lantus®, Lantus® SoloStar®, patent infringement suit, Sanofi
Paris, France, 30-1-2014 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that RobecoSAM, which measures the performance of companies in terms of corporate social responsibility (CSR), has included Sanofi for the seventh consecutive year in the 2014 Sustainability Yearbook published this month. … Read the full press release
Paris, France, 21-11-2013 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) announced today the decision to halt all clinical trials and cancel plans for regulatory filings with its investigational JAK2 inhibitor, fedratinib (SAR302503). Following a thorough risk-benefit analysis, including consultation with the U.S. … Read the full press release
Paris, France, 12-11-2013 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) announces that it has successfully priced its offering of EUR 1 billion of notes, due 2023, bearing interest at an annual rate of 2.50%. The issue is drawn under the Company’s Euro … Read the full press release
Posted in Business, Financial, France, Healthcare, Investment, Pharma & Biotech, Science
Tagged bond, bookrunners, Citi, EURONEXT: SAN, HSBC, Laurence Bollack, NYSE: SNY, Sanofi, Santander GBM, Sébastien Martel, The Royal Bank of Scotland
Cdiffense trial to evaluate vaccine against a leading cause of life-threatening, healthcare-associated infections worldwide Lyon, France, 06-8-2013 — /EuropaWire/ — Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the initiation of its Phase III clinical program … Read the full press release
Posted in Business, France, Healthcare, Pharma & Biotech, Science
Tagged Alain Bernal, C. diff, Cdiffense, Cdiffense Phase III clinical program, Cdiffense trial, Clostridium difficile infection, intestinal disease, Investigational Clostridium Difficile Vaccine, John Shiver PhD, life-threatening infections, Sanofi, Sanofi Pasteur, Sanofi vaccines division, Susan Watkins, symptomatic Clostridium difficile infection (CDI)
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?